FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
758 letters match. Newest first.
-
AnimalEvolution Pets LLC
Evolution Pets marketed SeizureGuard Plus and Life Span Arthritis & Mobility as unapproved drugs for treating dog diseases.
High risk -
AnimalNutrition Strength Ltd.
FDA warns Nutrition Strength Ltd. over unapproved dog seizure and blood-support supplements marketed as animal drugs.
High risk -
AnimalEnergetic Essences, LLC dba Pet Essences
FDA warned Pet Essences that its Seizures formula is an unapproved new animal drug marketed to treat seizures in animals.
High risk -
AnimalVeterinary Select Formula dba Allergic Pet
FDA warns Allergic Pet over unapproved Nuroplex animal drugs marketed for seizures and epilepsy in dogs and cats.
High risk -
AnimalIntermarket Industries Inc. dba Doc Ackerman Pet Products
FDA warns Doc Ackerman Pet Products that its Epilepsy & Seizure Formula for dogs and cats is an unapproved new animal drug.
High risk -
FoodGuangzhou Sinocon Food Co., Ltd
FDA warns Guangzhou Sinocon Food over food-safety violations in ready-to-eat Oat Beta Glucan powder, including pathogen hazards and inaccurate test certificates.
High risk -
DrugsBhargava Phytolab Private Limited
FDA warns Bhargava Phytolab over drug and API current good manufacturing practice (CGMP) violations, including inadequate testing and sterility controls.
High risk -
DrugsViatris, Inc.
FDA warns Viatris that its Indore, India, drug plant had unreliable quality data and weak investigations.
High risk -
DrugsSombra Cosmetics, Inc.
FDA warned Sombra Cosmetics of OTC drug CGMP violations, including inadequate water controls and component testing.
High risk -
DrugsAkron Formulations India Private Limited
Akron Formulations India's over-the-counter drugs are adulterated due to manufacturing quality (CGMP) failures, including unqualified active ingredient (API) suppliers and inadequate microbial testing.
High risk -
DrugsBrands International Corporation
Brands International, a Canadian drug manufacturer, limited an FDA inspection and had manufacturing quality violations including mold contamination.
High risk -
TobaccoShindler Distribution Inc. d/b/a VapoRush
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsMicro Orgo Chem
Micro Orgo Chem in India failed CGMP for API drugs, including cleaning, process validation, stability and records.
High risk -
FoodWANABANA USA LLC
WanaBana USA LLC failed to verify foreign supplier safety for lead-contaminated apple cinnamon puree pouches.
High risk -
DrugsHan C. Phan, M.D.
FDA warns clinical investigator Dr. Han C. Phan over failure to follow a drug study’s protocol for required tests.
Medium -
FoodTova Industries, LLC
Tova Industries was cited for missing required heat-and-acidity process controls and filings for acidified pancake syrups, vanilla flavorings, and soy sauces.
High risk -
DevicesAdept Medical Ltd.
Adept Medical Ltd. warning letter cites quality system and premarket violations for NeoZoline ventilation tubes, including unvalidated sterilization.
High risk -
FoodBarohup Inc.
Barohup Inc. lacked foreign supplier verification for imported foods and kept importing enoki mushrooms after a Listeria finding.
High risk -
DrugsRichard W. Foltin, Ph.D.
FDA warned sponsor Dr. Richard W. Foltin for starting drug trials in people without an IND.
High risk -
DrugsUnexo Lifesciences, Private Limited
FDA warned Unexo Lifesciences over serious CGMP violations, including data integrity failures and torn batch records for U.S.-bound drugs.
High risk -
DrugsColgate-Palmolive/Tom's of Maine, Inc.
FDA cited Tom's of Maine for CGMP failures after finding objectionable microbes in water and toothpaste and inadequate complaint handling.
High risk -
DrugsTianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
FDA cited Tianjin Darentang Jingwanhong Pharmaceutical for limiting a drug inspection and manufacturing violations at its China plant.
High risk -
FoodGolden Shrimp Seafood Joint Stock Company
Golden Shrimp Seafood's frozen yellowfin tuna had an inadequate seafood safety plan for controlling histamine.
High risk -
DrugsArmstrong County Memorial Hospital
FDA warns Armstrong County Memorial Hospital review board over missing procedures and inadequate meeting minutes for drug research.
Medium -
AnimalArdent Animal Health, LLC
Ardent Animal Health marketed Acti-Stem Therapy and PureVet PRP as unapproved new animal drugs for dogs and cats.
Medium -
DrugsAnalytical Food Laboratories, Inc.
FDA warned contract testing lab Analytical Food Laboratories after inspection found unvalidated drug test methods and weak quality oversight.
High risk -
FoodFuture Best Trading Inc.
FDA found Listeria in imported enoki mushrooms and cited Future Best Trading for lacking required supplier verification records.
High risk -
FoodPaso Real Produce LLC
Paso Real Produce, a Texas importer, had no Foreign Supplier Verification Program at all for its imported avocados and limes — a repeat finding.
Medium -
BiologicsBlackfly Investments, LLC dba Molecular® Testing Labs
Blackfly Investments dba Molecular Testing Labs sells an HIV dried blood spot self-collection kit without FDA marketing authorization.
High risk -
DrugsOmni Lens Pvt. Ltd.
FDA warns Omni Lens about CGMP failures and misbranding of ophthalmic OTC drugs made by unregistered contract manufacturers.
High risk -
BiologicsPinnacle Transplant Technologies, LLC
FDA warns Pinnacle Transplant Technologies over unapproved injectable amniotic products and sterility CGMP failures.
High risk -
DrugsStokes Healthcare Inc. dba Epicur Pharma
Sterile compounding facility Epicur Pharma made drugs under insanitary conditions and with serious quality failures, FDA says.
High risk -
BiologicsHemarus LLC
Hemarus LLC failed blood-product manufacturing rules, including unapproved donor reinstatement and records signed when physician absent.
High risk -
FoodBacalao Giraldo, S.L.U.
FDA warns Spain's Bacalao Giraldo over inadequate HACCP controls for Clostridium botulinum in refrigerated and frozen desalted cod.
High risk -
FoodBernardo Farms, LLC
FDA: Bernardo Farms papaya farm in Pahoa, Hawaii, held papayas under insanitary conditions, with no field toilets and dirty tools.
High risk -
FoodProcesadora Marina De La Costa Oriental Del Lago C.A.
FDA found HACCP violations at Procesadora Marina, a Venezuelan crabmeat processor; RTE crab may be unsafe.
High risk -
DrugsMMC Healthcare Ltd.
FDA warned MMC Healthcare Ltd. in Chennai that its drug products violate manufacturing rules, citing backdated records, weak computer controls, and unvalidated test methods.
High risk -
DrugsLittle Moon Essentials, LLC
FDA warns Little Moon Essentials over CGMP failures and unapproved topical analgesic drugs made in Dania Beach, Florida.
High risk -
DrugsDiamond Chemical Co., Inc.
Diamond Chemical Co. in East Rutherford, NJ, made OTC hand sanitizers without required ingredient and finished-product testing or process validation.
High risk -
FoodBig Vegetarian Supply, Inc.
FDA cites Big Vegetarian Supply for missing FSVP written assurances for three imported foods.
Medium -
DrugsAerosol and Liquid Packaging, Inc.
FDA warns Aerosol and Liquid Packaging on CGMP failures and unapproved antiseptic spray claims.
High risk -
DrugsGreco Gas, Inc.
Greco Gas, Inc. released medical gases without identity or purity testing and without quality oversight.
High risk -
DrugsZydus Lifesciences Limited
FDA warned Zydus Lifesciences over cross-contamination and glass particles in its injectable drugs, leading to recalls.
High risk -
DrugsOrean Personal Care Ltd.
FDA warned Orean Personal Care Ltd. that repeat manufacturing failures make its OTC drugs adulterated.
High risk -
AnimalCalifornia Veterinary Supply
FDA warned California Veterinary Supply for selling unapproved, unlisted antimicrobial fish and bird drugs online without FDA approval.
High risk -
DrugsRegenerative Processing Plant, LLC
FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.
High risk -
DevicesWissner-Bosserhoff GmbH
FDA warns German nursing bed maker Wissner-Bosserhoff over quality system failures and an unreported SafeControl handset correction.
High risk -
BiologicsMother Stem Institute, Corp.
FDA warns Mother Stem Institute over unapproved fat-derived SVF 'stem cell' biologic marketed for serious diseases.
High risk -
DrugsKaylaan LLC
FDA warns Kaylaan LLC that its fluoride toothpaste tablets were made without release testing, raw material identity testing, and adequate CGMP controls.
High risk -
Animal1 Stop Chicken Health Shop
FDA warns 1 Stop Chicken Health Shop over selling unapproved animal drugs, including toltrazuril and enrofloxacin, for poultry and other birds.
High risk